NCT05686980View on ClinicalTrials.gov

A Study to Assess the Adverse Events and How Oral ABBV-552 Capsules Moves Through the Body of Healthy Adult Japanese and Han Chinese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 17, 2023

Primary Completion Date

March 30, 2023

Study Completion Date

March 30, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

ABBV-552

Oral Capsule

Trial Locations (2)

92801-2658

Anaheim Clinical Trials LLC /ID# 252203, Anaheim

89113-2235

PPD Clinical Research Unit -Las Vegas /ID# 252241, Las Vegas

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY